ArticleJournal for immunotherapy of cancer2024

Angiotensin receptor blocker attacks armored and cold tumors and boosts immune checkpoint blockade.

Jie Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.